Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, H.A.D.M. Ashab et al.|European Urology|2017Cited by 793
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ. Alfred Witjes, Antoine G. van der Heijden, Matthew I. Milowsky et al.|European Urology|2023Cited by 618
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, George N. Thalmann, Shahrokh F. Shariat et al.|World Journal of Urology|2016Cited by 471
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 GuidelinesAntoine G. van der Heijden, Michael Rink, Harman Max Bruins et al.|European Urology|2025Cited by 159
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Peter C. Black, Ewan A. Gibb et al.|Clinical Cancer Research|2018Cited by 126